首頁 › 肺癌 › 愛荷華 › Cedar Rapids
Cedar Rapids, IA 的 肺癌 臨床試驗
14 項針對 肺癌 的研究正在 Cedar Rapids（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- University of Iowa Hospitals & Clinics, Iowa City · 距離 25 英里
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
招募中1/2 期
- Local Institution - 0065, Iowa City · 距離 25 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · 距離 25 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- University of Iowa, Iowa City · 距離 25 英里
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- Helen G. Nassif Community Cancer Center, Cedar Rapids
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
招募中3 期
- Saint Luke's Hospital, Cedar Rapids
CHAMP Lung Cancer Screening Program
招募中
- University of Iowa, Iowa City · 距離 25 英里
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
招募中1/2 期
- University of Iowa Health Care, Iowa City · 距離 25 英里
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
招募中2 期
- University of Iowa Hospitals and Clinics, Iowa City · 距離 25 英里
Using Xe MRI to Guide Radiation Therapy for Lung Cancer
招募中2 期
- University of Iowa, Iowa City · 距離 25 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Iowa City · 距離 25 英里
其他城市的 肺癌 試驗
- Houston, TX78 項研究
- Boston, MA62 項研究
- New York City, NY60 項研究
- Los Angeles, CA45 項研究
- Arlington, VA41 項研究
- Washington, DC41 項研究
- Chicago, IL41 項研究
- Nashville, TN40 項研究
- Baltimore, MD40 項研究
- St. Louis, MO39 項研究
- Columbus, OH37 項研究
- Philadelphia, PA36 項研究
Cedar Rapids 的其他研究
- 非小細胞肺癌20 項研究
- 乳癌17 項研究
- 癌症（所有類型）16 項研究
- 急性髓系白血病16 項研究
- 多發性骨髓瘤15 項研究
- 大腸直腸癌13 項研究
- 頭頸部鱗狀細胞癌12 項研究
- 前列腺癌12 項研究
- 中風10 項研究
- 黑色素瘤10 項研究
- 子宮內膜癌9 項研究
- 血液癌症9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。